“george-scangos” Archives

in
Entry Author Date Location
Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More 08/05/16 National
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
With Biogen at a Crossroads, CEO Scangos to Step Down 07/21/16 Boston
Biogen’s Nerve Repair Drug Fails MS Study, Shares Fall 06/07/16 Boston
East Coast Biotech Roundup: Homology, Biogen, Intellia & More 05/05/16 Boston
Sharpening Neuro Focus, Biogen to Spin Out Hemophilia Biz 05/03/16 Boston
Ready Or Not: Next Alzheimer’s Drugs Might Strain Health Systems 04/19/16 National
East Coast Biotech Roundup: Scangos, CRISPR, Yumanity, Synlogic & More 02/11/16 New York
Biogen’s Scangos on Pricing, Deals, Hemophilia, Alzheimer’s & More 02/09/16 Boston
Biogen to Cut 400 Jobs in Massachusetts in Big Restructuring 10/21/15 Boston
At Exelixis, Morrissey Dreams Of Getting the Band Back Together 06/01/15 San Francisco
Exelixis Axes 70% of Workforce as Cancer Drug Flops, Shares Routed 09/02/14 San Francisco
The Big Guys Have Lost Their Iron Grip, and It’s All Good 01/20/14 National
East Coast Life Sciences Roundup: Biogen Idec, Celgene, Alnylam, More 02/08/13 Boston
Join Us for ‘Boston Biotech Seizes the Momentum’ on April 4 02/07/13 Boston
Biogen ALS Failure Highlights Clinical Trial Frustrations 01/10/13 Boston
Biogen Idec’s ALS Drug Fails Phase III Trial 01/03/13 Boston
New England’s Emerging Biotech Stars: An Xconomy Forum In Pictures 04/09/12 Boston
See You Today at New England’s Emerging Biotech Stars***SOLD OUT*** 04/04/12 Boston
Third Rock’s Mark Levin: ‘Ultra-Super Positive’ on Biotech Innovation 03/29/12 Boston
Genocea CEO Chip Clark to Speak at Xconomy’s April 4 Biotech Forum 03/15/12 Boston
New England’s Emerging Biotech Stars: The Agenda 03/08/12 Boston
How Biogen Idec Overhauled R&D Under Doug Williams 03/07/12 Boston
Disease Foundations Play Growing Role in Biotech Business Model 03/06/12 San Francisco
Why Biogen Idec Got Out of the Corporate VC Business 01/27/12 Boston
New England’s Rising Biotech CEOs to Gather at April 4 Xconomy Event 01/26/12 Boston
Editor’s Picks: Xconomy Boston’s Top 20ish Stories of 2011 12/28/11 Boston
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the Third Quarter 10/28/11 Boston
Portola Grabs $45M Upfront From Biogen Idec to Develop Autoimmune Drugs 10/27/11 San Francisco
Fearless Fantasy Football, Uh, I Mean Biotech, Predictions for the Season Ahead 09/06/11 National
Page 1 of 2 next page »